By a News Reporter-Staff News Editor at Life Science Weekly -- A new study on Immune System Diseases and Conditions - HIV/AIDS is now available. According to news reporting out of Wayne, New Jersey, by NewsRx editors, research stated, “Antiretroviral (ARV) medicines reduce the risk of transmitting the HIV virus and are recommended as daily pre-exposure prophylaxis (PrEP) in combination with safer sex practices for HIV-negative individuals at a high risk for infection, but are underused in HIV prevention. Previous literature suggests that YouTube is extensively used to share health information.”
Our news journalists obtained a quote from the research from William Paterson University, “While pre-exposure prophylaxis (PrEP) is a novel and promising approach to HIV prevention, there is limited understanding of YouTube videos as a source of information on PrEP. The objective of this study was to describe the sources, characteristics, and content of the most widely viewed PrEP YouTube videos published up to October 1, 2016. The keywords ‘pre-exposure prophylaxis’ and ‘Truvada’ were used to find 217 videos with a view count >100. Videos were coded for source, view count, length, number of comments, and selected aspects of content. Videos were also assessed for the most likely target audience. The total cumulative number of views was >2.3 million, however, a single Centers for Disease Control and Prevention video accounted for >1.2 million of the total cumulative views. A great majority (181/217, 83.4%) of the videos promoted the use of PrEP, whereas 60.8% (132/217) identified the specific target audience. In contrast, only 35.9% (78/217) of the videos mentioned how to obtain PrEP, whereas less than one third addressed the costs, side effects, and safety aspects relating to PrEP. Medical and academic institutions were the sources of the largest number of videos (66/217, 30.4%), followed by consumers (63/217, 29.0%), community-based organizations (CBO; 48/217, 22.1%), and media (40/217, 18.4%). Videos uploaded by the media sources were more likely to discuss the cost of PrEP (p <.001), whereas the use of PrEP was less likely to be promoted in videos uploaded by individual consumers (p=.002) and more likely to be promoted in videos originated by CBOs (p=.009). The most common target audience for the videos was gay and bisexual men. YouTube videos can be used to share reliable PrEP information with individuals.”
According to the news editors, the research concluded: “Further research is needed to identify the best practices for using this medium to promote and increase PrEP uptake.”
For more information on this research see: Pre-Exposure Prophylaxis YouTube Videos: Content Evaluation. Jmir Public Health and Surveillance , 2018;4(1):e19.
Our news journalists report that additional information may be obtained by contacting A. Kecojevic, Dept. of Public Health, William Paterson University, Wayne, NJ, United States. Additional authors for this research include C. Basch, C. Basch and W. Kernan.
The direct object identifier (DOI) for that additional information is: https://doi.org/10.2196/publichealth.7733. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
CITATION: (2018-03-06), Data on HIV/AIDS Reported by Researchers at William Paterson University (Pre-Exposure Prophylaxis YouTube Videos: Content Evaluation), Life Science Weekly, 1749, ISSN: 1552-2474, BUTTER® ID: 015245883
From the newsletter Life Science Weekly.
https://www.newsrx.com/Butter/#!Search:a=15245883
This is a NewsRx® article created by NewsRx® and posted by NewsRx®. As proof that we are NewsRx® posting NewsRx® content, we have added a link to this steemit page on our main corporate website. The link is at the bottom left under "site links" at https://www.newsrx.com/NewsRxCorp/.
We have been in business for more than 20 years and our full contact information is available on our main corporate website.
We only upvote our posts after at least one other user has upvoted the article to increase the curation awards of upvoters.
NewsRx® offers 195 weekly newsletters providing comprehensive information on all professional topics, ranging from health, pharma and life science to business, tech, energy, law, and finance. Our newsletters report only the most relevant and authoritative information from qualified sources.